KKR is said to consider selling $750 million stake in JB Pharma
The US private equity firm is working with an investment bank as it considers selling about $750 million worth of stock in the Indian-listed company known as JB Pharma, the people said, asking not to be identified because the matter is private.

What's Your Reaction?






